BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2713854)

  • 1. Optimization of perfluorochemical levels with radiation therapy in mice.
    Teicher BA; Herman TS; Jones SM
    Cancer Res; 1989 May; 49(10):2693-7. PubMed ID: 2713854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy.
    Teicher BA; Herman TS; Jones SM
    Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):945-51. PubMed ID: 2211263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen-carrying perfluorochemical emulsion as an adjuvant to radiation therapy in mice.
    Teicher BA; Rose CM
    Cancer Res; 1984 Oct; 44(10):4285-8. PubMed ID: 6467189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
    Holden SA; Teicher BA; McIntosh NL; Rose CM
    Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
    Hishikawa-Itoh Y; Kato T; Niwa T; Ayakawa Y; Miyata N
    Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1243-8. PubMed ID: 2794648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiosensitization of Lewis lung tumor by perfluorochemical emulsion comparison between single and fractionated irradiation].
    Hishikawa-itoh Y; Miyata N
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):781-7. PubMed ID: 2142500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
    Martin DF; Porter EA; Fischer JJ; Rockwell S
    Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A; Menke D; Dorie MJ; Brown JM
    Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.
    Teicher BA; Holden SA; Northey D; Dewhirst MW; Herman TS
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):103-9. PubMed ID: 8482616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
    Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
    Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
    Teicher BA; Holden SA; Ara G; Ha CS; Herman TS; Northey D
    J Cancer Res Clin Oncol; 1992; 118(7):509-14. PubMed ID: 1624542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy.
    Griffin RJ; Williams BW; Park HJ; Song CW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1516-22. PubMed ID: 15817358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
    Rodrigues LM; Howe FA; Griffiths JR; Robinson SP
    J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation.
    Teicher BA; Herman TS; Hopkins RE; Menon K
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):969-74. PubMed ID: 1917627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiosensitization effects of perfluorochemical emulsion to LLC tumor mice with fractionated irradiation under oxygen breathing and radiotoxicity to normal mice].
    Itoh YH; Ayakawa Y; Miyata N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Dec; 47(12):1588-95. PubMed ID: 3452792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.